ZACHARY CASTOR: Open Payments
NPI 1760882112 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,944 in 24 payments from 10 companies in 2025. Trend: 2023 $256 · 2024 $409 · 2025 $4,944
Speaker / faculty: $2,520Travel & lodging: $1,833Food & beverage: $501Education: $90
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 13 | $4,610 |
| Janssen Biotech, Inc. | 2 | $110 |
| UROGEN PHARMA, INC. | 2 | $63 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Dendreon Pharmaceuticals LLC | 1 | $27 |
| Calyxo, Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| ACCORD HEALTHCARE, INC. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: KEYTRUDA, ERLEADA, LYNPARZA, JELMYTO, PROVENGE, CVAC ASPIRATION SYSTEM, ADSTILADRIN, Camcevi.
Industry payments across KS — which companies pay providers there.
